Buckle your seatbelts because this has been a busy week for research news at Children’s Hospital of Philadelphia.
Category Archive: Hematology
Using gene therapy to produce a mutant human protein with unusually high blood-clotting power, scientists have successfully treated animals with the bleeding disorder hemophilia.
The Children’s Hospital of Philadelphia’s Lacramioara Ivanciu, PhD, was one of five investigators who recently received funding through the Bayer Hemophilia Awards Program (BHAP).
Cell biologists at The Children’s Hospital of Philadelphia Research Institute speculate that platelet granules hold the key to unlocking the mechanisms behind Hermansky-Pudlak syndrome.
In two new studies, investigators from CHOP reprogrammed skin cells from patients with rare disorders into induced pluripotent stem cells (iPSCs).